|
Jazz Pharmaceuticals $108mm IPO
|
 Neurology
and psychiatry
Prospectus
SEC
filings
Underwriters
/ Advisors
- Morgan Stanley / Lehman Brothers
- Cooley Godward / Davis Polk
|
Response Genetics $21mm IPO / SB-2
|
Pharmacogenomic
cancer diagnostic tests
Prospectus
SEC
filings Underwriters
/ Advisors
- Maxim Group / Caris & Company
- Mintz Levin / Ellenoff Grossman
|
Amicus Therapeutics $75mm IPO
|
Pharmacological
chaperones - Human genetic diseases
Prospectus
SEC
filings
Underwriters
/ Advisors
- Morgan Stanley / Merrill Lynch
- Bingham McCutchen / Ropes & Gray
|
Helicos Biosciences
$48.6mm IPO - S-1
|
Innovative
genetic analysis technologies
Prospectus
SEC
filings
Underwriters
/ Advisors
- Morgan Stanley / Lehman Brothers
- Cooley Godward / Davis Polk
|
Developments
Index
Filed
Molecular Insight
|
Molecular
imaging pharmaceuticals
Underwriters
/ Advisors
- Piper Jaffray / SG Cowen
- Foley & Lardner / Willkie Farr
 SEC Filings
Filed
agreements
|
Altus Pharma
|
Protein
therapeutics for gastrointestinal disorders
Underwriters
/ Advisors
- Merrill Lynch / Morgan Stanley
- Mintz Levin / Wilmer Cutler Hale
SEC Filings
Filed
agreements
|
Somaxon Pharma
|
Products for psychiatry and neurology
Underwriters
/ Advisors
- Morgan Stanley / JP Morgan
- Latham / Davis Polk
SEC Filings
Filed
agreements
|
Acorda Therapeutics
|
Novel
therapies that improve neurological function
-
To treat MS, SCI and central nervous system disorders
Underwriters
/ Advisors
- Banc of America Securities
- Covington & Burling / Shearman & Sterling
SEC Filings
Filed
agreements
|
Iomai
|
Small
molecule therapeutics for oncology
Underwriters
/ Advisors
- UBS / SG Cowen
- Ropes & Gray / Dewey Ballantine
SEC Filings
Filed
agreements
|
SGX Pharma
|
Innovative
cancer therapeutics
Underwriters
/ Advisors
- CIBC / Piper Jaffray
- Cooley Godward / Latham
SEC Filings
- Includes lock-up agreement as an exhibit
Filed
agreements
|
Predix Pharma
|
Small
molecule drugs that target
G-Protein Coupled Receptors (GPCRs) and ion channels
Underwriters
/ Advisors
- UBS / Deutsche Bank
- Mintz Levin / Morrison & Foerster
SEC Filings
Filed
agreements
|
Amphastar Pharma
|
Injectable
and inhalation products
Underwriters
/ Advisors
- Lehman / UBS / Citigroup
- Latham & Watkins / Clifford Chance
SEC Filings
Filed
agreements
|
XenoPort
|
Products
that use the bodys natural nutrient transporter mechanisms to improve the
therapeutic benefits of existing drugs
Underwriters
/ Advisors
- Morgan Stanley / Deutsche Bank
- Cooley Godward / Davis Polk
SEC Filings
- Includes lock-up agreement as an exhibit
Filed
agreements
|
Priced
CombinatoRx
|
Develops
new medicines from synergistic combinations of approved drugs
- Sold 6mm shares at $7.00
- Original pricing range was $10 to $12
- Range lowered to $7 to $9
Underwriters
/ Advisors
- SG Cowen /
- Ropes & Gray / Skadden
SEC Filings
- Includes lock-up agreement as an exhibit
Filed
agreements
|
NxStage Medical
|
Home
kidney dialysis
- 5.5mm shares sold at $10.00
-
Original price range was $13 to $15
-
Cut to $11 to $12
Underwriters
/ Advisors
- Merrill / Thomas Weisel
- Wilmer Cutler / Shearman & Sterling
SEC Filings
- Includes lock-up agreement and opinions as
exhibits
Filed
agreements
|
Accentia Pharma
|
Respiratory
disease and oncology
- 2.4mm shares sold at $8.00
- Original price range was $11 to $13
- Cut to $8 to $10
- Size of offering was then cut by 60%
Underwriters
/ Advisors
- Jefferies
- Foley & Lardner / Hogan & Hartson
SEC Filings
SEC_CODE_REF_0090001192884
- Includes lock-up agreement and opinions as
exhibits
Filed
agreements
|
Electro-Optical Sciences
|
Respiratory
disease and oncology
- 4.0mm shares sold at $5.00
Underwriters
/ Advisors
- ThinkEquity Partners
- Dreier / Greenberg Traurig
SEC Filings
- Includes lock-up agreement and opinions as
exhibits
Filed
agreements
|
Avalon Pharma
|
Small
molecule therapeutics for the treatment of cancer
- 2.75mm shares sold at $10.50
- Originally filed for 4.5mm shares at $10 to $12
- Then cut size by 39%, but kept $10 to $12 range
- Initial filing had Legg Mason as lead
Deal
details
Underwriters
/ Advisors
- Hambrecht / Legg Mason
- Hogan & Hartson / Venable
SEC Filings
- Includes lock-up agreement and opinions as
exhibits
Filed
agreements
|
Genomic Health
|
Genomic-based
clinical diagnostic tests for cancer
-
To enable individualized treatment decisions
-
$60.2 million IPO
- 5.0mm shares sold at $12.00
- Original range was $12 to $14
Underwriters
/ Advisors
- JPMorgan / Lehman
- Pillsbury Winthrop / Simpson Thacher
SEC Filings
- Includes lock-up agreement and opinions as
exhibits
Filed
agreements
|
Favrille
|
Small
molecule therapeutics for oncology
Underwriters
/ Advisors
- Lehman / SG Cowen
- Latham / Cooley Godward
SEC Filings
- Includes lock-up agreement and opinions as
exhibits
Filed
agreements
|
HemoSense
|
Handheld
blood coagulation monitoring systems
-
For monitoring warfarin medication
-
$19.25 million IPO
Underwriters
/ Advisors
- Originally filed with Hambrecht as lead
- Wilson Sonsini / Morgan Lewis
SEC Filings
Filed
agreements
|
Sunesis Pharma
|
Small
molecule therapeutics for oncology
- 6mm shares sold at $7.00
- Original range was $9 to $11
Underwriters
/ Advisors
- Lehman / SG Cowen
- Latham / Cooley Godward
SEC Filings
- Includes lock-up agreement and opinions as
exhibits
Filed
agreements
|
CryoCor
|
